 | This article includes a list of general references, but it lacks sufficient corresponding inline citations. (January 2021) |
Alfred Hauptmann (August 29, 1881, in Gleiwitz, Upper Silesia – April 5, 1948, in Boston, Massachusetts) was a German-Jewish psychiatrist and neurologist.[1]
His most important contribution remained the article written in 1912 on the effectiveness of the phenobarbital as an anti-epileptic. After his emigration, he and the internist Siegfried Thannhauser, who had also emigrated, described an autosomal dominant inherited myopathy for the first time in 1941, which is now known as Hauptmann-Thannhauser muscular dystrophy.[2]
- ^ Kumbier, E.; Haack, K. (2002). "Alfred Hauptmann - the fate of a german neurologist of jewish origin". Fortschritte der Neurologie-Psychiatrie. 70 (4): 204–209. doi:10.1055/s-2002-24643. PMID 11948435. S2CID 221311074.
- ^ Krasnianski, Michael; Ehrt, Uwe; Neudecker, Stephan; Zierz, Stephan (July 2004). "Alfred Hauptmann, Siegfried Thannhauser, and an endangered muscular disorder". Archives of Neurology. 61 (7): 1139–1141. doi:10.1001/archneur.61.7.1139. ISSN 0003-9942. PMID 15262752.